VU 0365114 interferes with or suppresses the transmission of signals between neurons in the nervous system. It targets mAChR5.
Molecular Weight
397.35
Molecular Formula
C22H14F3NO3
Targets
mAChR5
Form
Lyophilized powder
Purity
>98%
Applications
VU 0365114 can be studied extensively in the context of neuroscience and pharmacology, particularly in the field of neurological and psychiatric disorders such as Parkinson’s disease, Alzheimer’s disease, and addiction.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
